Clinical Trial Update: Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain [Phase 1, Phase 2]

View source ↗

Summary

A combined low-dose naltrexone and bupropion trial for smoking cessation with reduced weight gain was completed (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking

Drugs mentioned

• Naltrexone (Naltrexone)
• bupropion (bupropion)

Snippet

Sponsor: Yale University | Conditions: Smoking, Nicotine Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-02-05